Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled budesonide for children with acute asthma attack
IRCT20190106042260N2Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Mar 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in asthma comparing Intervention: nebulized budesonide with Control: nebulized normal saline placebo (2 arms). Primary endpoints: Cough rate, Wheezing score and 3 more. Started Mar 2020; status: completed.
02
Drugs
budesonide
03
Conditions
asthma
Beyond the preview
Go deeper on IRCT20190106042260N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190106042260N2.